Designing Phase II B trials in sarcopenia: the best target population
about
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trialsCurrent nutritional recommendations and novel dietary strategies to manage sarcopeniaBiomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on SarcopeniaClinical trials on sarcopenia: methodological issues regarding phase 3 trials.Geriatric syndromes: How to treat.
P2860
Designing Phase II B trials in sarcopenia: the best target population
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Designing Phase II B trials in sarcopenia: the best target population
@ast
Designing Phase II B trials in sarcopenia: the best target population
@en
type
label
Designing Phase II B trials in sarcopenia: the best target population
@ast
Designing Phase II B trials in sarcopenia: the best target population
@en
prefLabel
Designing Phase II B trials in sarcopenia: the best target population
@ast
Designing Phase II B trials in sarcopenia: the best target population
@en
P2860
P1476
Designing Phase II B trials in sarcopenia: the best target population
@en
P2093
P2860
P2888
P304
P356
10.1007/S12603-011-0058-9
P577
2011-08-01T00:00:00Z